| Literature DB >> 26238251 |
Ehud Banne1, Vardiella Meiner2, Avraham Shaag2,3, Rachel Katz-Brull4, Ayelet Gamliel4, Stanley Korman2,3, Smadar Horowitz Cederboim2, Morasha Plesser Duvdevani2, Ayala Frumkin2,3, Amir Zilkha5, Vadim Kapuller6, Dan Arbell6, Elite Cohen7, Smadar Eventov-Friedman7.
Abstract
Transaldolase (TALDO) deficiency has various clinical manifestations including liver dysfunction, hepatosplenomegaly, anemia, thrombocytopenia, and dysmorphic features. We report a case presenting prenatally with hyperechogenic bowel and intrauterine growth restriction. The infant was born small for gestational age, with cutis laxa and hypertrichosis. Postnatally, meconium plug was identified, complicated with intestinal obstruction necessitating laparotomy, partial resection of the intestine, and ileostomy. Liver biopsy revealed cholangiolar proliferation and portal fibrosis. He also suffered from persistent congenital thrombocytopenia requiring platelet transfusions and severe hypothyroidism with normal anatomical and structural gland responding only to the combination of T3 and T4 treatment. Neurologically, severe hypotonia and anisocoria were noted at the age of 2 months. Brain MRI was normal. Shortly after the abdominal surgery, a rapid liver failure ensued, which eventually led to his death. Specific metabolic tests ruled out glycosylation disorders, yet urine analysis using 1H NMR showed accumulation of sedoheptulose which was previously described in patients with transaldolase deficiency. Sequencing of the gene-encoding transaldolase (TALDO1) revealed a homozygous stop mutation c.669C>G; p.Tyr223*. In conclusion, we present an infant with a novel homozygous mutation in TALDO1, causing TALDO deficiency, and extend the clinical characteristics of this rare syndrome.Entities:
Keywords: Cutis laxa; Echogenic bowel; Hypothyroidism; Microarray analysis; Transaldolase
Year: 2015 PMID: 26238251 PMCID: PMC4864716 DOI: 10.1007/8904_2015_474
Source DB: PubMed Journal: JIMD Rep ISSN: 2192-8304